Literature DB >> 2437444

Involvement of the 2'-5' A pathway in the augmentation of natural killer activity.

A Schmidt, B Crisp, D Krause, R H Silverman, R B Herberman, J R Ortaldo.   

Abstract

Pretreatment of human large granular lymphocytes (LGL) or unseparated peripheral blood mononuclear cells with interferon (IFN) resulted in a significant augmentation of natural killer (NK) activity. This increase was paralleled by an increase in the 2'-5'A synthetase activity. In order to investigate the possibility that IFN might be inducing augmentation of NK cells via the 2'-5'A pathway, we tested the effects of nonphosphorylated core material [(A2'p)2A] and of the triphosphorylated form of the 2'-5'A [ppp(A2'p)2A]. The core material had no detectable effect on NK activity. In contrast, when experiments were performed with the triphosphorylated form of 2'-5'A, NK activity was stimulated. In order to achieve activation, permeabilization of LGL with calcium chloride was necessary and, under these conditions, a dose-dependent augmentation of NK activity was seen. However, the calcium treatment had considerable toxic effects on basal levels of NK activity. Collectively, these results suggest that IFN may be inducing augmentation of NK activity via the 2'-5'A pathway. Further studies will be necessary to determine the effects of IFN and/or 2'-5'A on subsequent activation steps in the process leading to cytotoxicity by NK cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437444

Source DB:  PubMed          Journal:  Nat Immun Cell Growth Regul        ISSN: 0254-7600


  3 in total

Review 1.  Regulation of natural killer activity.

Authors:  J R Ortaldo
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.

Authors:  D N SenGupta; R H Silverman
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

Review 3.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.